NCT05921435

Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetic After Oral Administration of CKD-341 and D958 in Healthy Adults

A Phase I Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetic Characteristics After Administration of D958 and CKD-341 in Healthy Adult Volunteers

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 48 (actual)
• Sponsor: Chong Kun Dang Pharmaceutical · Industry
• Sex: All
• Age: 19 Years
• Healthy volunteers: Accepted

Summary

A clinical trial to compare and evaluate the safety and pharmacokinetics of CKD-341

Detailed description

A Randomized, Open-label, Oral, Single-dose, 2-treatment, Replicate crossover, 4-period Stuy

Conditions

• Hypertension

Interventions

Type	Name	Description
DRUG	CKD-341, D958	A single dose of 1tablet under fasting condition

Timeline

• Start date: 2023-06-20
• Primary completion: 2023-09-01
• Completion: 2023-09-15
• First posted: 2023-06-27
• Last updated: 2024-02-05

Locations

1 site across 1 country: South Korea